Reduction of Exposure, Inflammation, and Oxidative Stress Following At Least 2 Years of Switching to THS Use Compared to Cigarette Smoking

CompletedOBSERVATIONAL
Enrollment

952

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

December 27, 2023

Study Completion Date

April 23, 2024

Conditions
InflammationOxidative StressSmokingSmoking Abstinence
Interventions
OTHER

THS use

N/A: No intervention was assigned.

OTHER

Cigarette smoking

N/A: No intervention was assigned.

OTHER

Smoking abstinence

N/A: No intervention was assigned.

Trial Locations (37)

1069

Klinische Forschung Dresden GmbH, Sachsen

2600

Medical Centre Asklepii, Kyustendil

4103

Velocity Clinical Research Leipzig, Leipzig

5500

Medical Centre Leo Clinic EOOD, Lovech

6000

Medical Center Zara-Med EOOD, Stara Zagora

7200

Medical Center ReSpiro, Razgrad

10787

Velocity Clinical Research Germany GmbH, Berlin

15000

Praglandia s.r.o., Prague

20253

Klinische Forschung Hamburg GmbH, Hamburg

23758

Schaum/Hecht_RED Institut fur medizinische Forschung und Fortbildung GmbH, Oldenburg in Holstein

30159

Klinische Forschung Hannover-Mitte GmbH, Hanover

33401

Ordinance praktickeho lekai'e, Přeštice

56403

Aristotle University Thessaloniki/Papageorgiou Hospital, Thessaloniki

60313

Synexus Clinical Research GmbH, Frankfurt

76137

Klinische Forschung Karlsruhe GmbH, Karlsruhe

77900

PreventaMed s.r.o., Olomouc

1600017

Samoncho Clinic, Tokyo

2320064

Yokohama Minoru Clinic, Kanagawa

5320003

OPHAC Hospital, Osaka

6560853

OCROM Clinic, Osaka

360 17

Private Internal ambulance, Karlovy Vary

Unknown

Clintrial s.r.o., Prague

Vestra Clinics s.r.o., Rychnov nad Kněžnou

emovis GmbH, Berlin

Centrum für Diagnostik und Gesundheit, Klinische Forschung und Entwicklung, München

Praxis Reinfeld Mitte, Reinfeld

National and Kapodistrian University of Athens, Medical school, Attikon Hospital, 2nd Cardiology Department, Athens

Hakata Clinic, Fukuoka

Nishikumamoto Hospital, Minami

Sumida Hospital, Tokyo

398 11

Zdravi - fit, s.r.o., Protivín

160-0008

ToCROM Clinic, Tokyo

40-081

Centrum Medyczne Pratia, Katowice

40-156

Clinical Medical Research Sp. z o.o., Katowice

31-353

Tomed Tomasz Miszalski-Jamka, Krakow

90-127

Synexus Polska Sp zoo OddziaL w Lodzi, Lodz

05-830

Bioresearch Group, Nadarzyn

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY